Anne Jouinot - Concepedia

Author

Anne Jouinot

Assistance Publique – Hôpitaux de Paris ORCID

Also Known As

A Jouinot, A. Jouinot, Anne JOUINOT, Anne Jouinot, Jouinot Anne, Jouinot, Anne, Laurence Jonard, Rossella Libé

224

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Assistance Publique – Hôpitaux de Paris Université Paris Cité Hôpital Cochin Inserm Centre National de la Recherche Scientifique

About

Anne Jouinot is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.5K
2	Health Sciences	3	3	121
3	Endocrinology	2	2	358
4	Public Health	1	1	38
5	Applied Physiology	1	1	54

Anne Jouinot

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Integrated genomic characterization of adrenocortical carcinoma Guillaume Assié, Éric Letouzé, Anne Jouinot, Nature Genetics PathologyCancer GenomicsAdrenal DiseaseMedicineGenomic Characterization	2014	716
Pangenomic Classification of Pituitary Neuroendocrine Tumors Mario Néou, Chiara Villa, Roberta Armignacco, Cancer Cell Neuro-oncologyNeuroanatomyPangenomic ClassificationHistopathologyNeuroendocrine Disorder	2019	305
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux‐Leprieur, Cancers	2020	110
Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy , Clara Vazeille, Anne Jouinot, Jean-Philippe Durand, American Journal of Clinical Nutrition OncologyCancer ManagementPathologyAnticancer TherapyCancer Patients	2017	95
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients Valentine Heidelberger, François Goldwasser, N. Kramkimel, Investigational New Drugs MedicineAnti-pd1 Checkpoint InhibitorsImmunologyMelanomaPathology	2017	86
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma Guillaume Assié, Anne Jouinot, Rossella Libé, JAMA Oncology	2019	79
DNA methylation is an independent prognostic marker of survival in adrenocortical cancer Anne Jouinot, Guillaume Assié, Rossella Libé, The Journal of Clinical Endocrinology & Metabolism	2016	66
Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene <i>ARMC5</i> in 352 unselected patients Lucas Bouys, Anna Vaczlavik, Anne Jouinot, European Journal of Endocrinology	2022	57
Creatinine-to-cystatin C ratio and bioelectrical impedance analysis for the assessement of low lean body mass in cancer patients: Comparison to L3–computed tomography scan Guillaume Ulmann, Jean-Philippe Durand, N. Neveux, Nutrition Body CompositionKinesiologyExercise PhysiologyCreatinine-to-cystatin C RatioBioelectrical Impedance Analysis	2020	54
KDM1A inactivation causes hereditary food-dependent Cushing syndrome Anna Vaczlavik, Lucas Bouys, Florian Violon, Genetics in Medicine Metabolic SyndromeDisease MechanismGenetic DisorderGeneticsPhysiology	2021	53

Page 1